{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:04:03Z","timestamp":1791925443748,"version":"4.3.4"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.phymed.2026.158590","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:20:50Z","timestamp":1784042450000},"page":"158590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Bioactive compounds from traditional Chinese medicine for mitochondrial dysfunction-oriented nanodelivery in neurodegenerative diseases"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0779-4272","authenticated-orcid":false,"given":"Ting","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8268-9291","authenticated-orcid":false,"given":"Wenming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2026.158590_bib0001","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/1061186X.2017.1354002","article-title":"Neuroprotective effects of a biodegradable poly(lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: a potential nanotherapy for Alzheimer's disease?","volume":"26","author":"Aalinkeel","year":"2018","journal-title":"J. Drug Target."},{"key":"10.1016\/j.phymed.2026.158590_bib0002","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/ph15030281","article-title":"Lipid nanocarriers overlaid with chitosan for brain delivery of berberine via the nasal route","volume":"15","author":"Abo El-Enin","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.phymed.2026.158590_bib0003","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.7150\/thno.72167","article-title":"Selective brain entry of lipid nanoparticles in haemorrhagic stroke is linked to biphasic blood-brain barrier disruption","volume":"12","author":"Al-Ahmady","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.phymed.2026.158590_bib0004","first-page":"119","article-title":"Triphenylphosphine-based mitochondrial targeting nanocarriers: advancing cancer therapy","volume":"17","author":"Ali","year":"2025","journal-title":"Clin. Pharmacol. Adv. Appl."},{"key":"10.1016\/j.phymed.2026.158590_bib0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, Parkinson\u2019s disease, Huntington\u2019s disease and amyotrophic lateral sclerosis: an updated review","volume":"71","author":"Alqahtani","year":"2023","journal-title":"Mitochondrion"},{"key":"10.1016\/j.phymed.2026.158590_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.149693","article-title":"Neuroprotective potential of epigallocatechin gallate in neurodegenerative diseases: insights into molecular mechanisms and clinical relevance","volume":"1860","author":"Amin","year":"2025","journal-title":"Brain Res."},{"key":"10.1016\/j.phymed.2026.158590_bib0007","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41573-024-01105-0","article-title":"Targeting mitophagy in neurodegenerative diseases","volume":"24","author":"Antico","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2026.158590_bib0008","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/ph17050612","article-title":"Blood-brain barrier-targeting nanoparticles: biomaterial properties and biomedical applications in translational neuroscience","volume":"17","author":"Asimakidou","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.phymed.2026.158590_bib0009","article-title":"Intelligent nanoparticle design: unlocking the potential of AI for transformative drug delivery","volume":"36","author":"Azimi","year":"2025","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"10.1016\/j.phymed.2026.158590_bib0010","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.2174\/0113816128352935250116064725","article-title":"Inorganic nanoparticles-based drug delivery systems for neurodegenerative diseases therapy","volume":"31","author":"Bagherpour","year":"2025","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phymed.2026.158590_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113595","article-title":"Mechanisms of receptor-mediated transcytosis at the blood-brain barrier","volume":"381","author":"Baghirov","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phymed.2026.158590_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103983","article-title":"TPP-based conjugates: potential targeting ligands","volume":"29","author":"Batheja","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phymed.2026.158590_bib0013","doi-asserted-by":"crossref","first-page":"23202","DOI":"10.1039\/D5NR02548F","article-title":"Crossing the blood-brain barrier: advances in dendrimer-based nanocarriers for central nervous system delivery","volume":"17","author":"Bharadwaj","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.phymed.2026.158590_bib0014","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3390\/biomedicines13061464","article-title":"Next-generation drug delivery for neurotherapeutics: the promise of stimuli-triggered nanocarriers","volume":"13","author":"Boyuklieva","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.phymed.2026.158590_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1563701","article-title":"Mitochondria-targeted nanoparticles for the treatment of mitochondrial dysfunction-associated brain disorders","volume":"13","author":"Buck","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.phymed.2026.158590_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1123188","article-title":"Role of traditional Chinese medicine in ameliorating mitochondrial dysfunction via non-coding RNA signaling: implication in the treatment of neurodegenerative diseases","volume":"14","author":"Cai","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158590_bib0017","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3390\/molecules30030654","article-title":"Epigallocatechin gallate (EGCG): pharmacological properties, biological activities and therapeutic potential","volume":"30","author":"Capasso","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2026.158590_bib0018","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.3390\/ijms26157342","article-title":"Investigating neuroprotective effects of berberine on mitochondrial dysfunction and autophagy impairment in Parkinson's disease","volume":"26","author":"Cha","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2026.158590_bib0019","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.7150\/ijbs.102424","article-title":"Targeting mitochondria by lipid-selenium conjugate drug results in malate\/fumarate exhaustion and induces mitophagy-mediated necroptosis suppression","volume":"20","author":"Chang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phymed.2026.158590_bib0020","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1002\/ptr.70008","article-title":"Potential candidates of natural antioxidants from herbs for treating lung disorders: focus on redox balance and natural products","volume":"39","author":"Chang","year":"2025","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phymed.2026.158590_bib0021","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.3390\/ijms25147952","article-title":"Targeting mitochondrial dysfunction and reactive oxygen species for neurodegenerative disease treatment","volume":"25","author":"Choi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2026.158590_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1599167","article-title":"Molecular mechanisms of neuroprotective effect of rutin","volume":"16","author":"Chunmei","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158590_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2025.108217","article-title":"Dementia prevention, intervention, and care: comments on the 2024 report of the Lancet standing Commission","volume":"195","author":"Depypere","year":"2025","journal-title":"Maturitas"},{"key":"10.1016\/j.phymed.2026.158590_bib0024","doi-asserted-by":"crossref","first-page":"8899","DOI":"10.1007\/s00210-025-03815-7","article-title":"Ginkgolide B regulates apoptosis, oxidative stress, and mitochondrial dysfunction in MPP(+)-induced SK-N-SH cells by targeting HDAC4\/JNK pathway","volume":"398","author":"Ding","year":"2025","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158590_bib0025","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12668-025-01834-5","article-title":"Neuroprotective potential of baicalin nanocrystals: optimisation, comprehensive in vitro SH-SY5Y cell studies and in vivo pharmacokinetics","volume":"15","author":"Fadnis","year":"2025","journal-title":"BioNanoScience"},{"key":"10.1016\/j.phymed.2026.158590_bib0026","doi-asserted-by":"crossref","first-page":"27151","DOI":"10.1039\/D5NR02611C","article-title":"Nanotechnologies for traditional Chinese medicine research: quality control and therapeutic applications","volume":"17","author":"Fan","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.phymed.2026.158590_bib0027","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1038\/s41467-024-47867-4","article-title":"Mitochondrial complex I deficiency stratifies idiopathic Parkinson's disease","volume":"15","author":"Fl\u00f8nes","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2026.158590_bib0028","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.3390\/molecules26216531","article-title":"Huperzine A and its neuroprotective molecular signaling in Alzheimer's disease","volume":"26","author":"Friedli","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2026.158590_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103469","article-title":"Mitochondrial-targeted nanoparticles: delivery and therapeutic agents in cancer","volume":"28","author":"Ganji","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phymed.2026.158590_bib0030","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/10717544.2020.1760960","article-title":"RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery","volume":"27","author":"Hao","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.phymed.2026.158590_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2024.1360302","article-title":"Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria","volume":"4","author":"Haqqani","year":"2024","journal-title":"Front. Drug Deliv."},{"key":"10.1016\/j.phymed.2026.158590_bib0032","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s13346-025-01887-9","article-title":"Crossing the blood-brain barrier: nanoparticle-based strategies for neurodegenerative disease therapy","volume":"16","author":"Haro-Mart\u00ednez","year":"2026","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.phymed.2026.158590_bib0033","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1007\/s13346-023-01482-w","article-title":"ApoE-functionalization of nanoparticles for targeted brain delivery-a feasible method for polyplexes?","volume":"14","author":"Hartl","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.phymed.2026.158590_bib0034","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s13346-023-01407-7","article-title":"Chitosan-coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in Parkinson's disease: interplay between nuclear factor-kappa \u03b2 and cathepsin B","volume":"14","author":"Hassan","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.phymed.2026.158590_bib0035","article-title":"Curcumin simultaneously improves mitochondrial dynamics and myocardial cell bioenergy after sepsis via the SIRT1-DRP1\/PGC-1\u03b1 pathway","volume":"10","author":"Hou","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.phymed.2026.158590_bib0036","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jphotobiol.2018.11.008","article-title":"A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid \u03b2 aggregation in Alzheimer's disease","volume":"190","author":"Huo","year":"2019","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.phymed.2026.158590_bib0037","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12951-025-03109-3","article-title":"Drug delivery strategies with lipid-based nanoparticles for Alzheimer's disease treatment","volume":"23","author":"Jang","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phymed.2026.158590_bib0038","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1038\/s41467-025-61381-1","article-title":"Author correction: mitochondrion-specific dendritic lipopeptide liposomes for targeted sub-cellular delivery","volume":"16","author":"Jiang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2026.158590_bib0039","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.2147\/IJN.S214657","article-title":"The optimization design of lactoferrin-loaded HupA nanoemulsion for targeted drug transport via intranasal route","volume":"14","author":"Jiang","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.phymed.2026.158590_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.108043","article-title":"Ginsenoside Re binds Drp1 Leu94 across species to restore mitochondrial homeostasis via Atg1\/ULK1-dependent fission-mitophagy coupling in age-related degeneration","volume":"222","author":"Jin","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2026.158590_bib0041","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13804","article-title":"The application of polymeric nanoparticles as drug delivery carriers to cells in neurodegenerative diseases","volume":"58","author":"Jin","year":"2025","journal-title":"Cell Prolif."},{"key":"10.1016\/j.phymed.2026.158590_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2022.111290","article-title":"Mitochondria-targeted and pH-triggered charge-convertible polymeric micelles for anticancer therapy","volume":"224","author":"Jin","year":"2022","journal-title":"Mater. Des."},{"key":"10.1016\/j.phymed.2026.158590_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2024.102000","article-title":"Mitochondria-targeted nanotherapeutics: a new frontier in neurodegenerative disease treatment","volume":"81","author":"Keethedeth","year":"2025","journal-title":"Mitochondrion"},{"key":"10.1016\/j.phymed.2026.158590_bib0044","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41531-025-01081-1","article-title":"Revamping Parkinson's disease therapy using PLGA-based drug delivery systems","volume":"11","author":"Lababidi","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.phymed.2026.158590_bib0045","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.2147\/IJN.S525960","article-title":"Potential applications of natural components of traditional Chinese medicine delivery via nanoparticle drug delivery systems in the treatment of Alzheimer's disease","volume":"20","author":"Lai","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.phymed.2026.158590_bib0046","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1007\/s11064-024-04129-5","article-title":"Binary nano-inhalant formulation of icariin enhances cognitive function in vascular dementia via BDNF\/TrkB signaling and anti-inflammatory effects","volume":"49","author":"Li","year":"2024","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.phymed.2026.158590_bib0047","article-title":"Advancements in mitochondrial-targeted nanotherapeutics: overcoming biological obstacles and optimizing drug delivery","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2026.158590_bib0048","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/molecules22020277","article-title":"Resveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer's disease","volume":"22","author":"Loureiro","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2026.158590_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123930","article-title":"Enhanced brain distribution of Ginsenoside F1 via intranasal administration in combination with absorption enhancers","volume":"654","author":"Mao","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phymed.2026.158590_bib0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12951-025-03352-8","article-title":"Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies","volume":"23","author":"Mehdizadeh","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phymed.2026.158590_bib0051","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3390\/biomedicines13020327","article-title":"Mitochondrial dysfunction in neurodegenerative diseases: mechanisms and corresponding therapeutic strategies","volume":"13","author":"Meng","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.phymed.2026.158590_bib0052","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/IJN.S151474","article-title":"Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease","volume":"13","author":"Meng","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.phymed.2026.158590_bib0053","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1039\/D5NH00277J","article-title":"Nano-Chinese herbal medicines and their delivery strategies for central nervous system disease therapy","volume":"10","author":"Mu","year":"2025","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.phymed.2026.158590_bib0054","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41556-024-01513-9","article-title":"The role of PINK1-Parkin in mitochondrial quality control","volume":"26","author":"Narendra","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phymed.2026.158590_bib0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s40360-025-01039-2","article-title":"Innovative approach in Parkinson's targeting via berberine-loaded mucoadhesive surface-modified liposomes: a multi-faceted study","volume":"26","author":"Nematalla","year":"2025","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.phymed.2026.158590_bib0056","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-03671-8","article-title":"Lipid nanoparticle delivery of the CRISPR\/Cas9 system directly into the mitochondria of cells carrying m.7778G>T mutation in MtDNA (mt-Atp8)","volume":"15","author":"Norota","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2026.158590_bib0057","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11033-025-10368-8","article-title":"Pharmacological approaches to enhance mitochondrial biogenesis: focus on PGC-1\u0391, AMPK, and SIRT1 in cellular health","volume":"52","author":"Palabiyik","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.phymed.2026.158590_bib0058","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1039\/D3MA00629H","article-title":"Circumventing challenges in mitochondrial targeting for cancer treatment: leveraging nanoplatforms for effective solutions","volume":"5","author":"Pandya","year":"2024","journal-title":"Mater. Adv."},{"key":"10.1016\/j.phymed.2026.158590_bib0059","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10456-024-09938-4","article-title":"Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction","volume":"27","author":"Pang","year":"2024","journal-title":"Angiogenesis"},{"key":"10.1016\/j.phymed.2026.158590_bib0060","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.3390\/ijms21228846","article-title":"Curcumin-loaded nanoparticles based on amphiphilic hyaluronan-conjugate explored as targeting delivery system for neurodegenerative disorders","volume":"21","author":"Pepe","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2026.158590_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1271175","article-title":"Editorial: mitochondrial dysfunction as a target in neurodegenerative diseases","volume":"16","author":"Perrone","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.phymed.2026.158590_bib0062","article-title":"Neuroprotective effects of curcumin-loaded solid lipid nanoparticles on homocysteine-induced oxidative stress in vascular dementia","volume":"2","author":"Prathipati","year":"2021","journal-title":"Curr. Res. Behav. Sci."},{"key":"10.1016\/j.phymed.2026.158590_bib0063","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jgr.2025.04.006","article-title":"Ginsenoside Rb1 attenuates coronary microvascular inflammatory injury via NDUFS4-SIRT5-DUSP1-mediated mitochondrial quality control in a murine ischemia-reperfusion model","volume":"49","author":"Pu","year":"2025","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.phymed.2026.158590_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156982","article-title":"Tanshinone IIA modulates Sirt5 and Metll3 interaction to govern mitochondria-endoplasmic reticulum unfolded protein response in coronary microvascular injury","volume":"145","author":"Pu","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158590_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119990","article-title":"Berberine-loaded nanostructured lipid carrier for Alzheimer's disease: design, statistical optimization and enhanced in vivo performance","volume":"285","author":"Raju","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2026.158590_bib0066","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12668-024-01695-4","article-title":"Evaluation of neuroprotective effects of polymeric berberine nanoparticles against Parkinson\u2019s rat model","volume":"15","author":"Rayapudi","year":"2025","journal-title":"BioNanoScience"},{"key":"10.1016\/j.phymed.2026.158590_bib0067","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1515\/revneuro-2024-0086","article-title":"Recent advances on brain drug delivery via nanoparticles: alternative future materials for neuroscience applications; a review","volume":"36","author":"Razavi","year":"2025","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.phymed.2026.158590_bib0068","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12951-025-03528-2","article-title":"Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids: advances and challenges","volume":"23","author":"Sanadgol","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phymed.2026.158590_bib0069","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/1061186X.2024.2437440","article-title":"Mitochondrial-targeted liposome-based drug delivery - therapeutic potential and challenges","volume":"33","author":"Sanchez-Aranguren","year":"2025","journal-title":"J. Drug Target."},{"key":"10.1016\/j.phymed.2026.158590_bib0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12017-013-8261-y","article-title":"Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington\u2019s disease","volume":"16","author":"Sandhir","year":"2014","journal-title":"NeuroMol. Med."},{"key":"10.1016\/j.phymed.2026.158590_bib0071","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1186\/s12951-025-03667-6","article-title":"A novel ligustrazine-based nanodelivery system protects against doxorubicin-induced cardiotoxicity by targeting the SIRT5-DUSP1 axis for mitochondrial repair","volume":"23","author":"Shi","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phymed.2026.158590_bib0072","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021","volume":"388","author":"Su","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.phymed.2026.158590_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125875","article-title":"Cell membrane-coated nanoparticles for neurodegenerative disorders management","volume":"681","author":"Thakur","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phymed.2026.158590_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124686","article-title":"The piper at the gates of brain: a systematic review of surface modification strategies on lipid nanoparticles to overcome the Blood-Brain-Barrier","volume":"665","author":"Vargas","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phymed.2026.158590_bib0075","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"DNA-PKcs-Driven YAP1 phosphorylation and nuclear translocation: a key regulator of ferroptosis in hyperglycemia-induced cardiac dysfunction in Type 1 Diabetes","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.phymed.2026.158590_bib0076","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.7150\/ijbs.95853","article-title":"Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia\/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy","volume":"20","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phymed.2026.158590_bib0077","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12951-025-03420-z","article-title":"Ligustrazine nano-drug delivery system ameliorates doxorubicin-mediated myocardial injury via piezo-type mechanosensitive ion channel component 1-prohibitin 2-mediated mitochondrial quality surveillance","volume":"23","author":"Wang","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phymed.2026.158590_bib0078","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.1039\/D1RA00550B","article-title":"Application progress of RVG peptides to facilitate the delivery of therapeutic agents into the central nervous system","volume":"11","author":"Wang","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.phymed.2026.158590_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102667","article-title":"Oxidative stress and mitochondrial impairment: key drivers in neurodegenerative disorders","volume":"104","author":"Wen","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.phymed.2026.158590_bib0080","doi-asserted-by":"crossref","first-page":"e613","DOI":"10.1212\/WNL.0000000000207474","article-title":"Global prevalence and incidence of amyotrophic lateral sclerosis: a systematic review","volume":"101","author":"Wolfson","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.phymed.2026.158590_bib0081","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.phymed.2026.158590_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118223","article-title":"Leonurus japonicus Houtt. modulates neuronal apoptosis in intracerebral hemorrhage: insights from network pharmacology and molecular docking","volume":"330","author":"Wu","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2026.158590_bib0083","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/s12951-025-03748-6","article-title":"Apigenin regulates CCR5\/JAK1\/STAT1\/MMPs signaling to alleviate secondary brain injury after intracerebral hemorrhage and its enhanced delivery via targeted nanoparticles","volume":"23","author":"Wu","year":"2025","journal-title":"Jo J. Nanobiotechnol."},{"key":"10.1016\/j.phymed.2026.158590_bib0084","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70609","article-title":"Network pharmacology-based and experimental validation elucidate the target mechanism of vinorine in ameliorating secondary brain injury after intracerebral hemorrhage","volume":"31","author":"Wu","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.phymed.2026.158590_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.118486","article-title":"Uncovering the effects of ATBC plasticizers on intracerebral hemorrhage outcomes based on network toxicology and in vitro and in vivo experimental validation","volume":"300","author":"Wu","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.phymed.2026.158590_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2024.106650","article-title":"Microtubules and cardiovascular diseases: insights into pathology and therapeutic strategies","volume":"175","author":"Wu","year":"2024","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.phymed.2026.158590_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101146","article-title":"Mitochondrial quality control disorder in neurodegenerative disorders: potential and advantages of traditional Chinese medicines","volume":"15","author":"Xu","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.phymed.2026.158590_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101034","article-title":"Potential of natural drug modulation of endoplasmic reticulum stress in the treatment of myocardial injury","volume":"14","author":"Yang","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.phymed.2026.158590_bib0089","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.70042","article-title":"Comprehensive characterization of the chemical constituents, serum pharmacochemistry, and quality control of jieyu pills utilizing UHPLC-orbitrap fusion MS","volume":"40","author":"Ye","year":"2026","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.phymed.2026.158590_bib0090","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41467-025-68024-5","article-title":"Intranasal blood-brain barrier bypass enables sequential mitochondria-targeted bioengineered nanolamellar system for ischemic stroke therapy","volume":"17","author":"Yin","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2026.158590_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2025.115692","article-title":"Neuroprotective effects of quercetin on motor impairments and anxiety-like behaviors in a rat model of Parkinson's disease","volume":"493","author":"Yousefi","year":"2025","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phymed.2026.158590_bib0092","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s12951-025-03572-y","article-title":"Recent advances of engineering cell membranes for nanomedicine delivery across the blood-brain barrier","volume":"23","author":"Yuan","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phymed.2026.158590_bib0093","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bioactmat.2024.09.039","article-title":"A tailored phytosomes based nose-to-brain drug delivery strategy: silver bullet for Alzheimer's disease","volume":"44","author":"Yue","year":"2025","journal-title":"Bioactive Mater."},{"key":"10.1016\/j.phymed.2026.158590_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215616","article-title":"Recent advances of nanomaterials for intervention in Parkinson\u2019s disease in the context of anti-inflammation","volume":"502","author":"Zhang","year":"2024","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.phymed.2026.158590_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157288","article-title":"Astragaloside VI attenuates mechanical stress-induced cardiac remodeling through piezo1-VDAC1 dependent endoplasmic reticulum unfolded protein response","volume":"148","author":"Zhang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158590_bib0096","doi-asserted-by":"crossref","first-page":"14667","DOI":"10.2147\/IJN.S562666","article-title":"Mitochondria-targeted nanosystems in the treatment of central nervous system diseases","volume":"20","author":"Zhang","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.phymed.2026.158590_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102168","article-title":"Cascade-targeting multifunctional nanochaperone remodels brain microenvironment for synergistic therapy of Alzheimer\u2019s disease","volume":"55","author":"Zhang","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.phymed.2026.158590_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2022.116690","article-title":"Analytical and biomedical applications of nanomaterials in Chinese herbal medicines research","volume":"156","author":"Zhang","year":"2022","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.phymed.2026.158590_bib0099","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jbiotec.2024.08.008","article-title":"Nanozymes targeting mitochondrial repair in disease treatment","volume":"394","author":"Zhang","year":"2024","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.phymed.2026.158590_bib0100","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1016\/j.apsb.2023.06.011","article-title":"Mitochondrial-targeted and ROS-responsive nanocarrier via nose-to-brain pathway for ischemic stroke treatment","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2026.158590_bib0101","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00210-024-03319-w","article-title":"Interaction between resveratrol and SIRT1: role in neurodegenerative diseases","volume":"398","author":"Zhu","year":"2025","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158590_bib0102","doi-asserted-by":"crossref","first-page":"8791","DOI":"10.1039\/D3NR06102G","article-title":"Unleashing the potential: integrating nano-delivery systems with traditional Chinese medicine","volume":"16","author":"Zou","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.phymed.2026.158590_bib0103","first-page":"1874","article-title":"Interpretation of the \u201cGuidelines for Nanodrug Quality Control Research (Trial)\u201d","volume":"59","author":"Zhang","year":"2024","journal-title":"Chin. J. Pharmacol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326008214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326008214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:44:23Z","timestamp":1785509063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326008214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":103,"alternative-id":["S0944711326008214"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158590","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioactive compounds from traditional Chinese medicine for mitochondrial dysfunction-oriented nanodelivery in neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158590"}}